The UK's High Court revoked Human Genome Sciences' patent on neutrokine-alpha, a protein involved in a number of inflammatory diseases, such as arthritis, asthma and chronic pulmonary disease, says the Financial Times.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.